MYRIAD GENETICS, INC. Capitalized Computer Software, Net
MYRIAD GENETICS, INC. (MYGN) had Capitalized Computer Software, Net of $7.10 million as of 2022-12-31, per its 10-K filed 2023-03-01.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization
us-gaap:CapitalizedComputerSoftwareNet · last filed 2023-03-01
- 2022-12-31: Capitalized Computer Software, Net $7.10M.
- 2021-12-31: Capitalized Computer Software, Net $6.70M.
- 2020-12-31: Capitalized Computer Software, Net $2.30M.
| Period end | Capitalized Computer Software, Net |
|---|---|
| 2022-12-31 | $7.10M 10-K · filed 2023-03-01 |
| 2021-12-31 | $6.70M 10-K · filed 2023-03-01 |
| 2020-12-31 | $2.30M 10-K · filed 2022-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |